Growth, Trends, and Opportunities in the Desmoid Tumors Market: Key Insights for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Long-Term Projected Growth Rate for the Desmoid Tumors Market, and What Are the Key Drivers?
Over the past few years, the market size for desmoid tumors has experienced robust growth. The market is projected to increase from $2.97 billion in 2024 to $3.18 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth experienced in the historic period can be attributed to progress in medical imaging, advancements in genetic research and understanding, surgical innovation, as well as increased awareness, education, and patient advocacy.
Anticipated to witness robust expansion in the forthcoming years, the market size of desmoid tumors is projected to reach $4.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. The rise in the predicted period is due to factors such as bespoke treatments, individualized medicine, increased global partnerships, authorization of innovative therapies, and focus on patient-centered approaches. The forthcoming period will see major trends such as evolution in treatment methodologies, precision medicine and biomarker identification, clinical studies and research endeavors, multifaceted treatment teams, and patient advocacy and assistance.
What Strategic Factors Are Influencing the Accelerated Growth of the desmoid tumors Market?
Predicted growth in the desmoid tumor market is linked to the alarming increase in global cancer cases. Cancer is characterized by abnormal cell proliferation that tends to spread uncontrollably and can damage nearby tissues and organs. This upward trend in cancer incidences has stimulated a higher demand for advanced and efficient chemotherapeutic agents, impressing a positive impact on the desmoid tumor market. The National Cancer Institute, a US Federal agency, reported that by May 2024, the U.S. could expect 2,001,140 new cancer diagnoses and around 611,720 related fatalities. Moreover, around 20 million new cancer cases and 9.7 million cancer-linked deaths were recorded globally in 2022. Future projections predict that, by 2040, these figures could escalate to 29.9 million new cases and 15.3 million cancer-related deaths annually.
Desmoid Tumors Market Driver: Government Funding Facilitates Growth of Desmoid Tumor Market Via R&D Investments
Request Your Free Desmoid Tumors Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp
Which Companies Are Leading the Charge in Expanding the Desmoid Tumors Market?
Major companies operating in the desmoid tumors market report are:
• Pfizer Inc._x000D_
• F.Hoffmann-La Roche Ltd._x000D_
• AbbVie Inc._x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
What New Trends Are Reshaping the Desmoid Tumors Market and Its Opportunities?
Key players in the desmoid tumors market are focusing on the invention of advanced drugs, such as nirogacestat, to better cater to the requirements of their current users. Nirogacestat stands as an orally administered gamma-secretase inhibitor. SpringWorks Therapeutics Inc., a clinical-stage biopharmaceutical company located in the US, in February 2023, made public the acceptance, along with a priority review, of their fresh drug application (NDA) for nirogacestat to cater to adults suffering from desmoid tumors, by the U.S. Food and Drug Administration (FDA). The mechanism of nirogacestat is believed to involve the obstruction of the synthesis of notch proteins, thereby leading tumor cells to death. High levels of notch protein, often produced by desmoid tumors, are suspected to be a contributing factor to their growth. Nirogacestat, in addition, extends to patients a novel option for treatment that holds the potential to improve outcomes.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report
How Are Market Segments in the Desmoid Tumors Industry Positioned for Long-Term Growth?
The desmoid tumors market covered in this report is segmented –
1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments
2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis
3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users
Subsegments:
1) By Surgery: Wide Excision, Minimally Invasive Surgery
2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy
3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids
4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors
5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy
6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Therapies
7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies
What Are the Top Regions Fueling Growth in the Desmoid Tumors Market?
North America was the largest region in the desmoid tumors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Defines the Scope of the Desmoid Tumors Market?
Desmoid tumors refer to rare non-cancerous (benign) tumors that arise from connective tissue cells, usually in the fascia, which is the tissue that surrounds muscles, nerves, and blood vessels. These tumors are locally aggressive, which means they can grow and invade nearby structures but do not spread to distant parts of the body like traditional cancer.
Browse Through More Similar Reports By The Business Research Company:
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024
Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
